Literature DB >> 29082643

The experience of management of chronic hepatitis B in China.

H Ren1.   

Abstract

During the past 30 years, with the possible biggest population with chronic HBV infection in the world, the physicians and scientists in China have unique experience in the fight against HBV. Even though some drugs are not recommended anymore, but this kind of experience are very helpful for the development of new medicine and strategy against HBV.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  China; PEG-interferon; chronic hepatitis B; nucleos(t)ide

Mesh:

Year:  2017        PMID: 29082643     DOI: 10.1111/jvh.12793

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  Effects of Depression, Anxiety, Stigma, and Disclosure on Health-Related Quality of Life among Chronic Hepatitis B Patients in Dalian, China.

Authors:  Ge Li; Gongchen Wang; Fang-Chi Hsu; Jianzhao Xu; Xia Pei; Bo Zhao; Avinash Shetty
Journal:  Am J Trop Med Hyg       Date:  2020-05       Impact factor: 2.345

2.  Interface Hepatitis over Grade 2 May Differentiate Chronic Inflammation Associated with CHB from NAFLD in the Early Stage.

Authors:  Yong-Fen Zhu; Jin Wang; Jia-Zhui Fang; Qiao Yang; Fang-Fang Lv
Journal:  Gastroenterol Res Pract       Date:  2020-04-20       Impact factor: 2.260

3.  Comprehensive Analysis of the mRNA-lncRNA Co-expression Profile and ceRNA Networks Patterns in Chronic Hepatitis B.

Authors:  Wenbiao Chen; Chenhong Lin; Lan Gong; Jianing Chen; Yan Liang; Ping Zeng; Hongyan Diao
Journal:  Curr Genomics       Date:  2019-05       Impact factor: 2.236

4.  Renal Involvement and HBV Infection Are Common in Chinese Patients With Cryoglobulinemia.

Authors:  Wei Bai; Lixia Zhang; Jiuliang Zhao; Shangzhu Zhang; Jiaxin Zhou; Xiaomei Leng; Zhengyin Liu; Wenling Ye; Bing Han; Xinping Tian; Mengtao Li; Yan Zhao; Xiaofeng Zeng
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

5.  The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China.

Authors:  Bingfeng Han; Qianli Yuan; Yuhui Shi; Lai Wei; Jinlin Hou; Jia Shang; Ying Han; Cunduo Jin; Po-Lin Chan; Hui Zhuang; Jie Li; Fuqiang Cui
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

6.  Comorbidities and mortality risk among extensive-stage small-cell lung cancer patients in mainland China: impacts of hypertension, type 2 diabetes mellitus, and chronic hepatitis B virus infection.

Authors:  Weigang Xiu; Yin Huang; Yanying Li; Min Yu; Youling Gong
Journal:  Anticancer Drugs       Date:  2022-01-01       Impact factor: 2.248

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.